449 related articles for article (PubMed ID: 21291396)
1. Structural requirements to obtain highly potent and selective 18 kDa Translocator Protein (TSPO) Ligands.
Taliani S; Pugliesi I; Da Settimo F
Curr Top Med Chem; 2011; 11(7):860-86. PubMed ID: 21291396
[TBL] [Abstract][Full Text] [Related]
2. An update into the medicinal chemistry of translocator protein (TSPO) ligands.
Barresi E; Robello M; Costa B; Da Pozzo E; Baglini E; Salerno S; Da Settimo F; Martini C; Taliani S
Eur J Med Chem; 2021 Jan; 209():112924. PubMed ID: 33081988
[TBL] [Abstract][Full Text] [Related]
3. Channel-like functions of the 18-kDa translocator protein (TSPO): regulation of apoptosis and steroidogenesis as part of the host-defense response.
Veenman L; Papadopoulos V; Gavish M
Curr Pharm Des; 2007; 13(23):2385-405. PubMed ID: 17692008
[TBL] [Abstract][Full Text] [Related]
4. [18 kDa translocator protein--implications in cell's functions].
Kołodziejczyk A
Postepy Hig Med Dosw (Online); 2015 Jan; 69():34-50. PubMed ID: 25589712
[TBL] [Abstract][Full Text] [Related]
5. Translocator protein ligands as promising therapeutic tools for anxiety disorders.
Taliani S; Da Settimo F; Da Pozzo E; Chelli B; Martini C
Curr Med Chem; 2009; 16(26):3359-80. PubMed ID: 19548867
[TBL] [Abstract][Full Text] [Related]
6. VDAC activation by the 18 kDa translocator protein (TSPO), implications for apoptosis.
Veenman L; Shandalov Y; Gavish M
J Bioenerg Biomembr; 2008 Jun; 40(3):199-205. PubMed ID: 18670869
[TBL] [Abstract][Full Text] [Related]
7. Regulation of the mitochondrial permeability transition pore by the outer membrane does not involve the peripheral benzodiazepine receptor (Translocator Protein of 18 kDa (TSPO)).
Šileikytė J; Blachly-Dyson E; Sewell R; Carpi A; Menabò R; Di Lisa F; Ricchelli F; Bernardi P; Forte M
J Biol Chem; 2014 May; 289(20):13769-81. PubMed ID: 24692541
[TBL] [Abstract][Full Text] [Related]
8. Guwiyang Wurra--'Fire Mouse': a global gene knockout model for TSPO/PBR drug development, loss-of-function and mechanisms of compensation studies.
Middleton RJ; Liu GJ; Banati RB
Biochem Soc Trans; 2015 Aug; 43(4):553-8. PubMed ID: 26551692
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of TSPO ligands on mitochondrial function in mouse microglia cells.
Bader S; Wolf L; Milenkovic VM; Gruber M; Nothdurfter C; Rupprecht R; Wetzel CH
Psychoneuroendocrinology; 2019 Aug; 106():65-76. PubMed ID: 30954920
[TBL] [Abstract][Full Text] [Related]
10. Exploring Translocator Protein (TSPO) Medicinal Chemistry: An Approach for Targeting Radionuclides and Boron Atoms to Mitochondria.
Giordani A; Menziani MC; Moresco RM; Matarrese M; Paolino M; Saletti M; Giuliani G; Anzini M; Cappelli A
J Med Chem; 2021 Jul; 64(14):9649-9676. PubMed ID: 34254805
[TBL] [Abstract][Full Text] [Related]
11. Translocator protein as a promising target for novel anxiolytics.
Costa B; Da Pozzo E; Martini C
Curr Top Med Chem; 2012; 12(4):270-85. PubMed ID: 22204481
[TBL] [Abstract][Full Text] [Related]
12. The role of 18 kDa mitochondrial translocator protein (TSPO) in programmed cell death, and effects of steroids on TSPO expression.
Veenman L; Gavish M
Curr Mol Med; 2012 May; 12(4):398-412. PubMed ID: 22348610
[TBL] [Abstract][Full Text] [Related]
13. Computational studies on translocator protein (TSPO) and its ligands.
Ortore G; Tuccinardi T; Martinelli A
Curr Top Med Chem; 2012; 12(4):352-9. PubMed ID: 22204485
[TBL] [Abstract][Full Text] [Related]
14. Translocator protein (18 kDa) ligand PK 11195 induces transient mitochondrial Ca2+ release leading to transepithelial Cl- secretion in HT-29 human colon cancer cells.
Ostuni MA; Ducroc R; Péranzi G; Tonon MC; Papadopoulos V; Lacapere JJ
Biol Cell; 2007 Nov; 99(11):639-47. PubMed ID: 17561806
[TBL] [Abstract][Full Text] [Related]
15. Translocator protein (TSPO) in breast cancer.
Mukherjee S; Das SK
Curr Mol Med; 2012 May; 12(4):443-57. PubMed ID: 22348612
[TBL] [Abstract][Full Text] [Related]
16. Combined effect of G3139 and TSPO ligands on Ca(2+)-induced permeability transition in rat brain mitochondria.
Azarashvili T; Krestinina O; Baburina Y; Odinokova I; Grachev D; Papadopoulos V; Akatov V; Lemasters JJ; Reiser G
Arch Biochem Biophys; 2015 Dec; 587():70-7. PubMed ID: 26498031
[TBL] [Abstract][Full Text] [Related]
17. Design, Synthesis and Anxiolytic Activity Evaluation of N-Acyltryptophanyl- Containing Dipeptides, Potential TSPO Ligands.
Gudasheva TA; Deeva OA; Mokrov GV; Dyabina AS; Yarkova MA; Seredenin SB
Med Chem; 2019; 15(4):383-399. PubMed ID: 30457052
[TBL] [Abstract][Full Text] [Related]
18. Distribution, pharmacological characterization and function of the 18 kDa translocator protein in rat small intestine.
Ostuni MA; Péranzi G; Ducroc RA; Fasseu M; Vidic B; Dumont J; Papadopoulos V; Lacapere JJ
Biol Cell; 2009 Jul; 101(10):573-86. PubMed ID: 19392661
[TBL] [Abstract][Full Text] [Related]
19. Translocator protein: pharmacology and steroidogenesis.
Midzak A; Zirkin B; Papadopoulos V
Biochem Soc Trans; 2015 Aug; 43(4):572-8. PubMed ID: 26551695
[TBL] [Abstract][Full Text] [Related]
20. Translocator protein (18 kDa) as a pharmacological target in adipocytes to regulate glucose homeostasis.
Li J; Papadopoulos V
Biochem Pharmacol; 2015 Sep; 97(1):99-110. PubMed ID: 26123521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
